You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

de Novo Activated B-cell (ABC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)

Active, not recruiting
Has Results
  • Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
  • Los Angeles, California
  • +6 more
Dec 1, 2022

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • Indianapolis, Indiana
  • +1 more
Jul 12, 2022

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,

Suspended
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • +20 more
  • Tucson, Arizona
  • +110 more
Jan 31, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (lenalidomide, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • Fayetteville, Arkansas
  • +431 more
Nov 17, 2022

Hematological Malignancies - SANGUINE

Recruiting
  • Hematologic Malignancy
  • Blood sampling for HemaChip screening/diagnostic testing
  • Bone marrow sampling
  • Olomouc, Czechia
  • +3 more
Feb 9, 2023

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

Active, not recruiting
  • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
  • Großhansdorf, Germany
  • +17 more
Jan 12, 2023

Latin American Real-world Study in Acute Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
    • Montería, Colombia
      Oncomedica SA
    Jan 5, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    DLBCL, DLBCL Activated B-Cell Type, DLBCL Germinal Center B-Cell Type Trial in Chicago (Cyclophosphamide, Doxorubicin

    Active, not recruiting
    • Diffuse Large B-Cell Lymphoma
    • +6 more
    • Chicago, Illinois
      Northwestern University
    Apr 30, 2021

    AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

    Terminated
    Has Results
    • AML Including AML de Novo and AML Secondary to MDS
    • DLBCL
    • Birabresib Dose 20 mg
    • (no location specified)
    Aug 23, 2022

    Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

    Recruiting
    • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 13, 2022

    Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

    Recruiting
    • Neuroendocrine Prostate Cancer
    • Phoenix, Arizona
    • +19 more
    Aug 11, 2022

    Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • La Jolla, California
    • +107 more
    Mar 10, 2021

    Large B Cell Lymphoma Trial in United States (rituximab, cyclophosphamide, doxorubicin)

    Completed
    Has Results
    • Large B Cell Lymphoma
    • rituximab
    • +7 more
    • La Jolla, California
    • +46 more
    Nov 15, 2021

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

    Recruiting
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    • Frankfurt, Germany
      Department of Medicine, Hematology and Oncology, Goethe Universi
    Sep 24, 2023

    Real-World Data on First-line Treatment of Hormone

    Recruiting
    • Breast Cancer
      • Porto Alegre, Rio Grande Do Sul, Brazil
        CPO
      Aug 15, 2022

      High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

      Not yet recruiting
      • High-Risk de Novo Multiple Myeloma
      • Badalona, Spain
      • +9 more
      Apr 27, 2023

      MALT Lymphoma Trial in France, Italy, Switzerland (Chlorambucil, Rituximab i.v., Rituximab s.c.)

      Active, not recruiting
      • MALT Lymphoma
      • Créteil, France
      • +37 more
      Nov 4, 2022

      Calcified Coronary Lesions, ST Elevated Myocardial Infarction, Plaque Modification Technique Trial in Barcelona

      Recruiting
      • Calcified Coronary Lesions
      • +2 more
        • Barcelona, Spain
          Hospital del Mar
        Mar 1, 2023

        Early Detection of de Novo Cancer in Liver Transplant Recipients

        Completed
        • De Novo Cancer
        • Liver Transplant Disorder
          • (no location specified)
          Aug 5, 2022

          Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

          Not yet recruiting
          • Glioblastoma
          • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
          • Gainesville, Florida
            University of Florida Health
          Jul 29, 2022

          ddcfDNA in Kidney Transplant Recipients

          Recruiting
          • Kidney Transplant Rejection
          • AlloSeq cfDNA
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Aug 22, 2023

          Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

          Enrolling by invitation
          • Interstitial Fibrosis
          • +6 more
          • Houston, Texas
            Houston Methodist Research Institute
          Jan 23, 2023